Profile
Ingrid C.
Choong worked as a Senior Scientist at Sunesis Pharmaceuticals, Inc. from 1999 to 2008.
She then served as an Investor Relations Officer at Eiger BioPharmaceuticals, Inc. In 2008, she returned to Eiger BioPharmaceuticals, Inc. as the SVP-Clinical Development & Head-Investor Relations.
In terms of education, Dr. Choong obtained an undergraduate degree from the California Institute of Technology and a doctorate from the University of California, Berkeley.
Former positions of Ingrid Choong
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Investor Relations Contact | 2016-03-28 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2007-12-31 |
Training of Ingrid Choong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
- Stock Market
- Insiders
- Ingrid Choong
















